Volume 91, Number 6
Preexposure prophylaxis for preventing HIV infection: Routine practice in primary care
How to Obtain AMA PRA Category 1 Credit™ and ABIM MOC points
- Review information on this page.
- Read the journal article.
- Return to this page and select the "Complete the CME/MOC Process" link.
- Login to your myCME account.
- If claiming MOC, choose the 'CME & MOC' option and complete the posttest.
- Complete the registration / evaluation form.
- Print your personalized CME / MOC certificate.
Release Date: June 1, 2024
Expiration Date: May 31, 2025
Estimated Time of Completion: 1 hour
Description
The authors discuss how to conduct a sexual history to identify risk factors for exposure to human immunodeficiency virus and review the 3 available preexposure prophylaxis regimens: emtricitabine/tenofovir disoproxil fumarate, emtricitabine/tenofovir alafenamide, and injectable cabotegravir.
Learning Objective
Identify patients with an indication for preexposure prophylaxis for the prevention of human immunodeficiency virus infection and provide education about and access to preexposure prophylaxis medications for patients with an indication.
Target Audience
Directed to practitioners in family medicine and internal medicine.
ACCREDITATION STATEMENT
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CREDIT DESIGNATION
American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this journal-based activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
**Please Note** To receive MOC you must select the MOC option during the online credit claiming process and complete the required steps. ABIM MOC points will be reported within 30 days of claiming credit.
Activity Directors, Authors, and Other Contributors
Activity Director
Brian F. Mandell, MD, PhD
Chairman, Department of Academic Medicine, Education Institute,
Professor of Medicine, Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University,
Editor in Chief, Cleveland Clinic Journal of Medicine,
Cleveland Clinic,
Cleveland, OH
Co-Activity Directors
Craig D. Nielsen, MD, FACP
Vice Chairman, Department of Internal Medicine;
Associate Professor, Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University, Cleveland, OH;
Governor, Ohio Chapter, American College of Physicians;
Deputy Editor, Cleveland Clinic Journal of Medicine,
Cleveland Clinic,
Cleveland, OH
James C. Pile, MD
Department of Hospital Medicine;
Associate Professor, Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University, Cleveland, OH;
Deputy Editor, Cleveland Clinic Journal of Medicine,
Cleveland Clinic, Cleveland, OH
George Thomas, MD, MPH
Director, Center for Blood Pressure Disorders, Department of Kidney Medicine;
Associate Professor, Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University, Cleveland, OH;
Deputy Editor, Cleveland Clinic Journal of Medicine,
Cleveland Clinic,
Cleveland, OH
Mary T. Cusick, MS
Executive Editor, Cleveland Clinic Journal of Medicine,
Cleveland Clinic,
Cleveland, OH
Authors
Amy L. Wiser, MD, FAAFP, IBCLC
Cascade AIDS Project, Prism Health, Portland, OR
Other Contributors
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:
Brian F. Mandell, MD, PhD (Activity Director) | ||
Consulting, Research: DSMB | Horizon Pharma | |
Daniel J. Brotman, MD | ||
Research/PI in investigator-initiated study | Bristol-Myers Squibb Co. | |
Adam J. Brown, MD | ||
Consulting, teaching and speaking | Amgen | |
Abhijit Duggal, MD | ||
Advisor or review panel participant | Alung Technologies | |
Kristin Highland, MD | ||
Consulting, teaching and speaking | Acceleron Pharma Inc, Actelion, Bayer Healthcare, Boehringer Ingelheim, United Therapeutics Corporation | |
Advisor or review panel participant | Boehringer Ingelheim, United Therapeutics Corporation | |
Consulting | Forsee, Genentech/Roche | |
David Louis Keller, MD | ||
Ownership interest (stock, stock options in a publicly owned company) |
Glaxo Smith Kline, Johnson and Johnson, Pfizer | |
Angelo Licata, MD | ||
Ownership interest (stock, stock options in a publicly owned company) |
Merck & Co, Inc. | |
Christian Nasr, MD | ||
Advisor or review panel participant | Horizon Therapeutics, Nevro Corporatio | |
Consulting research: principal investigator | Siemens | |
Bernard J. Silver, MD | ||
Advisor or review panel participant | Takeda | |
Tyler Stevens, MD | ||
Teaching and speaking | Abbvie Pharmaceuticals | |
Consulting | Boston Scientific | |
Olaf Wendler, PhD | ||
Consulting | Edwards Lifesciences | |
All other authors, co-activity directors, reviewers and CCJM staff report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.
(Article opens in a new tab / window; return to this window to complete the activity).
This CME activity was produced by the Cleveland Clinic Journal of Medicine and the Cleveland Clinic Center for Continuing Education.
Center for Continuing Education | 9500 Euclid Avenue, JJ42 Cleveland, OH 44195
Center for Continuing Education | 9500 Euclid Avenue, JJ42 Cleveland, OH 44195